Literature DB >> 15085185

The emergence of Lyme disease.

Allen C Steere1, Jenifer Coburn, Lisa Glickstein.   

Abstract

Since its identification nearly 30 years ago, Lyme disease has continued to spread, and there have been increasing numbers of cases in the northeastern and north central US. The Lyme disease agent, Borrelia burgdorferi, causes infection by migration through tissues, adhesion to host cells, and evasion of immune clearance. Both innate and adaptive immune responses, especially macrophage- and antibody-mediated killing, are required for optimal control of the infection and spirochetal eradication. Ecological conditions favorable to the disease, and the challenge of prevention, predict that Lyme disease will be a continuing public health concern.

Entities:  

Mesh:

Year:  2004        PMID: 15085185      PMCID: PMC385417          DOI: 10.1172/JCI21681

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  97 in total

1.  The presenting manifestations of Lyme disease and the outcomes of treatment.

Authors:  Allen C Steere; Vijay K Sikand
Journal:  N Engl J Med       Date:  2003-06-12       Impact factor: 91.245

2.  How can we prevent Lyme disease?

Authors:  Edward B Hayes; Joseph Piesman
Journal:  N Engl J Med       Date:  2003-06-12       Impact factor: 91.245

3.  The early clinical manifestations of Lyme disease.

Authors:  A C Steere; N H Bartenhagen; J E Craft; G J Hutchinson; J H Newman; D W Rahn; L H Sigal; P N Spieler; K S Stenn; S E Malawista
Journal:  Ann Intern Med       Date:  1983-07       Impact factor: 25.391

4.  Susceptibility to experimental Lyme arthritis correlates with KC and monocyte chemoattractant protein-1 production in joints and requires neutrophil recruitment via CXCR2.

Authors:  Charles R Brown; Victoria A Blaho; Christie M Loiacono
Journal:  J Immunol       Date:  2003-07-15       Impact factor: 5.422

5.  Antibiotic use in relation to the risk of breast cancer.

Authors:  Christine M Velicer; Susan R Heckbert; Johanna W Lampe; John D Potter; Carol A Robertson; Stephen H Taplin
Journal:  JAMA       Date:  2004-02-18       Impact factor: 56.272

6.  Outer-surface protein C of the Lyme disease spirochete: a protein induced in ticks for infection of mammals.

Authors:  Dorothee Grimm; Kit Tilly; Rebecca Byram; Philip E Stewart; Jonathan G Krum; Dawn M Bueschel; Tom G Schwan; Paul F Policastro; Abdallah F Elias; Patricia A Rosa
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-17       Impact factor: 11.205

7.  Molecular phylogenetic analyses indicate that the Ixodes ricinus complex is a paraphyletic group.

Authors:  Guang Xu; Quentin Q Fang; James E Keirans; Lance A Durden
Journal:  J Parasitol       Date:  2003-06       Impact factor: 1.276

8.  Coevolution of markers of innate and adaptive immunity in skin and peripheral blood of patients with erythema migrans.

Authors:  Juan C Salazar; Constance D Pope; Timothy J Sellati; Henry M Feder; Thomas G Kiely; Kenneth R Dardick; Ronald L Buckman; Meagan W Moore; Melissa J Caimano; Jonathan G Pope; Peter J Krause; Justin D Radolf
Journal:  J Immunol       Date:  2003-09-01       Impact factor: 5.422

Review 9.  Elucidation of Lyme arthritis.

Authors:  Allen C Steere; Lisa Glickstein
Journal:  Nat Rev Immunol       Date:  2004-02       Impact factor: 53.106

10.  Asymptomatic infection with Borrelia burgdorferi.

Authors:  Allen C Steere; Vijay K Sikand; Robert T Schoen; John Nowakowski
Journal:  Clin Infect Dis       Date:  2003-07-30       Impact factor: 9.079

View more
  296 in total

1.  Functional analysis of Borrelia burgdorferi uvrA in DNA damage protection.

Authors:  Mariya Sambir; Larisa B Ivanova; Anton V Bryksin; Henry P Godfrey; Felipe C Cabello
Journal:  FEMS Microbiol Lett       Date:  2011-02-17       Impact factor: 2.742

2.  Emerging infectious diseases.

Authors:  Vincent R Racaniello
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

3.  Differential regulation of the multiple flagellins in spirochetes.

Authors:  Chunhao Li; Melanie Sal; Michael Marko; Nyles W Charon
Journal:  J Bacteriol       Date:  2010-03-19       Impact factor: 3.490

4.  Preventing broken Borrelia telomeres: ResT couples dual hairpin telomere formation with product release.

Authors:  Julien Briffotaux; Kerri Kobryn
Journal:  J Biol Chem       Date:  2010-10-14       Impact factor: 5.157

5.  CsrA modulates levels of lipoproteins and key regulators of gene expression critical for pathogenic mechanisms of Borrelia burgdorferi.

Authors:  S L Rajasekhar Karna; Eva Sanjuan; Maria D Esteve-Gassent; Christine L Miller; Mahulena Maruskova; J Seshu
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

6.  Vascular binding of a pathogen under shear force through mechanistically distinct sequential interactions with host macromolecules.

Authors:  Tara J Moriarty; Meiqing Shi; Yi-Pin Lin; Rhodaba Ebady; Hong Zhou; Tanya Odisho; Pierre-Olivier Hardy; Aydan Salman-Dilgimen; Jing Wu; Eric H Weening; Jon T Skare; Paul Kubes; John Leong; George Chaconas
Journal:  Mol Microbiol       Date:  2012-10-24       Impact factor: 3.501

7.  Cyclic Di-GMP receptor PlzA controls virulence gene expression through RpoS in Borrelia burgdorferi.

Authors:  Ming He; Jun-Jie Zhang; Meiping Ye; Yongliang Lou; X Frank Yang
Journal:  Infect Immun       Date:  2013-11-11       Impact factor: 3.441

8.  Elevated levels of IL-23 in a subset of patients with post-lyme disease symptoms following erythema migrans.

Authors:  Klemen Strle; Daša Stupica; Elise E Drouin; Allen C Steere; Franc Strle
Journal:  Clin Infect Dis       Date:  2013-11-11       Impact factor: 9.079

Review 9.  Evolution and population genomics of the Lyme borreliosis pathogen, Borrelia burgdorferi.

Authors:  Stephanie N Seifert; Camilo E Khatchikian; Wei Zhou; Dustin Brisson
Journal:  Trends Genet       Date:  2015-03-09       Impact factor: 11.639

10.  Interleukin-10 (IL-10) inhibits Borrelia burgdorferi-induced IL-17 production and attenuates IL-17-mediated Lyme arthritis.

Authors:  Emily S Hansen; Velinka Medić; Joseph Kuo; Thomas F Warner; Ronald F Schell; Dean T Nardelli
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.